Literature DB >> 12921293

The effect of mannose-binding protein gene polymorphisms in recurrent respiratory system infections in children and lung tuberculosis.

Filiz Ozbaş-Gerçeker1, Ilhan Tezcan, A Izzet Berkel, Seref Ozkara, Ayşenaz Ozcan, Fügen Ersoy, Ozden Sanal, Meral Ozgüç.   

Abstract

Mannose-binding lectin (MBL) is able to bind pathogens as an opsonin and plays an important role in the innate immunity. The aim of the present study was to determine the frequencies of the MBL gene variants in the Turkish population and to examine the presence of any association between MBL variants and development of tuberculosis (TB) in adults and recurrent respiratory tract infections in children. Two structural gene mutations in exon 1 of MBL gene (codon 54 and codon 57) were studied. The overall distribution of genotypes did not significantly differ between controls and TB patients/children with recurrent respiratory system infections. The frequency of allele B was calculated as 0.14, 0.09 and 0.06 for control, TB patients and children with recurrent respiratory system infections, respectively. It was found to be significantly lower in children with recurrent respiratory system infections than in controls (chi2: 4.68, d.f: 1, p: 0.030).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12921293

Source DB:  PubMed          Journal:  Turk J Pediatr        ISSN: 0041-4301            Impact factor:   0.552


  13 in total

Review 1.  Infections of people with complement deficiencies and patients who have undergone splenectomy.

Authors:  Sanjay Ram; Lisa A Lewis; Peter A Rice
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 2.  Mannose-binding lectin and susceptibility to tuberculosis: a meta-analysis.

Authors:  J T Denholm; E S McBryde; D P Eisen
Journal:  Clin Exp Immunol       Date:  2010-08-19       Impact factor: 4.330

Review 3.  C-type lectin receptors in tuberculosis: what we know.

Authors:  Surabhi Goyal; Tilman E Klassert; Hortense Slevogt
Journal:  Med Microbiol Immunol       Date:  2016-07-28       Impact factor: 3.402

4.  Low levels of mannose-binding lectin confers protection against tuberculosis in Turkish children.

Authors:  H Cosar; F Ozkinay; H Onay; N Bayram; A R Bakiler; M Anil; D Can; C Ozkinay
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-07-09       Impact factor: 3.267

5.  Mannose-binding lectin polymorphisms and recurrent respiratory tract infection in Chinese children.

Authors:  Jia Chen; Zhene Xu; Xi Ou; Mo Wang; Xiqiang Yang; Qiu Li
Journal:  Eur J Pediatr       Date:  2009-01-24       Impact factor: 3.183

Review 6.  A Meta-analysis of MBL2 Polymorphisms and Tuberculosis Risk.

Authors:  Mohammed Y Areeshi; Raju K Mandal; Naseem Akhter; Sajad A Dar; Arshad Jawed; Mohd Wahid; Harishankar Mahto; Aditya K Panda; Mohtashim Lohani; Shafiul Haque
Journal:  Sci Rep       Date:  2016-11-23       Impact factor: 4.379

7.  Genetic polymorphisms of exon 1 of MBL2 contribute to tuberculosis risk especially in Asian populations: an updated meta-analysis of 26 studies.

Authors:  Yu-Jiao Wu; Xin Yang; Ting-di Chen; Zhi-Xin Zhang; Yi-Zhong You; Zheng-da Fan
Journal:  Infect Drug Resist       Date:  2018-08-20       Impact factor: 4.003

Review 8.  Genetic polymorphisms of MBL2 and tuberculosis susceptibility: a meta-analysis of 22 case-control studies.

Authors:  Yan Cao; Xinjing Wang; Zhihong Cao; Chunyan Wu; Dongmei Wu; Xiaoxing Cheng
Journal:  Arch Med Sci       Date:  2017-01-20       Impact factor: 3.318

9.  Mannose-binding lectin promoter polymorphisms and gene variants in pulmonary tuberculosis patients from cantabria (northern Spain).

Authors:  J-Gonzalo Ocejo-Vinyals; Lucía Lavín-Alconero; Pablo Sánchez-Velasco; M-Ángeles Guerrero-Alonso; Fernando Ausín; M-Carmen Fariñas; Francisco Leyva-Cobián
Journal:  Pulm Med       Date:  2012-12-04

10.  Association between polymorphisms in mannose-binding lectin 2 gene with pulmonary tuberculosis susceptibility.

Authors:  Wenhao Shen; Li Xiao; Yang Li; Daming Zhou; Wei Zhang
Journal:  Hereditas       Date:  2020-08-03       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.